Literature DB >> 2004489

Monocytes secrete factors regulating glycosaminoglycan synthesis in mesangial cells in vitro.

I Narita1, T Morioka, M Arakawa, F Shimizu, T Oite.   

Abstract

The present study was conducted to determine the manner in which monocytes increase mesangial matrices, particularly glycosaminoglycans (GAGs) which interact with various other matrix components such as collagens, laminin, fibronectin and lipoproteins. A supernatant of human peripheral blood monocyte cultures activated by lipopolysaccharide (LPS) contains stimulating factors for glycosaminoglycan synthesis in rat mesangial cells (MCs). The culture supernatant in this study was concentrated and fractionated by gel chromatography and the GAG-stimulatory factor was found to have a molecular weight of 10-17 kD. This factor was shown to be present in fractions different from that of IL-1. Gel and ion-exchange chromatography studies of GAGs synthesized by MCs indicated the elution patterns of GAGs in the presence and absence of the monocyte culture supernatant to be essentially the same. Local infiltration of monocytes into the glomerulus, often seen in various types of glomerular injury, may be an important factor in the accumulation of the mesangial matrix.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004489      PMCID: PMC1535325          DOI: 10.1111/j.1365-2249.1991.tb05668.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

Review 1.  The biology of platelet-derived growth factor.

Authors:  R Ross; E W Raines; D F Bowen-Pope
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

2.  De novo cellular synthesis of sulfated proteoglycans of the developing renal glomerulus in vivo.

Authors:  Y S Kanwar; M L Jakubowski; L J Rosenzweig; J T Gibbons
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

3.  Stimulation of rat mesangial cell proliferation by macrophage interleukin 1.

Authors:  D H Lovett; J L Ryan; R B Sterzel
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

4.  Alterations in the extracellular matrix components in human glomerular diseases.

Authors:  A Oomura; T Nakamura; M Arakawa; A Ooshima; M Isemura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients.

Authors:  T L Whiteside; J G Worrall; R K Prince; R B Buckingham; G P Rodnan
Journal:  Arthritis Rheum       Date:  1985-02

6.  Modulation of Ia and leukocyte common antigen expression in rat glomeruli during the course of glomerulonephritis and aminonucleoside nephrosis.

Authors:  G F Schreiner; R S Cotran; E R Unanue
Journal:  Lab Invest       Date:  1984-11       Impact factor: 5.662

7.  Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells.

Authors:  J K Chen; H Hoshi; W L McKeehan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 8.  Focal and segmental glomerulosclerosis: analogies to atherosclerosis.

Authors:  J R Diamond; M J Karnovsky
Journal:  Kidney Int       Date:  1988-05       Impact factor: 10.612

9.  Endothelial cell behavior after denudation injury is modulated by transforming growth factor-beta1 and fibronectin.

Authors:  J A Madri; M A Reidy; O Kocher; L Bell
Journal:  Lab Invest       Date:  1989-06       Impact factor: 5.662

10.  Bovine brain and pituitary fibroblast growth factors: comparison of their abilities to support the proliferation of human and bovine vascular endothelial cells.

Authors:  D Gospodarowicz; J Cheng; M Lirette
Journal:  J Cell Biol       Date:  1983-12       Impact factor: 10.539

View more
  1 in total

1.  Modulation of human mesangial cell behaviour by extracellular matrix components--the possible role of interstitial type III collagen.

Authors:  K Saito; F Shimizu; T Sato; T Oite
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.